Results 301 to 310 of about 370,832 (346)

Pox Viral Vaccines

2004
Tumor-associated antigens (TAAs) are by definition either weakly immunogenic or functionally nonimmunogenic. Vaccine strategies must be developed in which the presentation of these TAAs to the immune system results in far greater activation of T cells than is being achieved naturally in the host.
James L. Gulley, Philip M. Arlen, Jeffrey Schlom   +2 more
openaire   +1 more source

Viral Hepatitis Vaccines

2011
HAV and HBV are prevalent worldwide, cause significant morbidity and mortality, and are vaccine-preventable.
Melissa L. Diamantis, Stephen K. Tyring
openaire   +1 more source

Viral DNA Vaccines

2001
Update on antiviral DNA vaccine research (1998-2000) optimization strategies for DNA vaccines relative potency of cellular and humoral immune responses induced by DNA vaccination improving DNA vaccines targeting viral infection alphavirus vectors - applications for DNA vaccine production and gene expression plasmid DNA vaccines - investigation of ...
openaire   +1 more source

Viral Vaccines

Vijay Singh Bohara, Sachin Kumar
  +4 more sources

Cardio‐oncology care in the era of the coronavirus disease 2019 (COVID‐19) pandemic: An International Cardio‐Oncology Society (ICOS) statement

Ca-A Cancer Journal for Clinicians, 2020
Daniel J Lenihan, Joseph Carver, Charles Porter   +2 more
exaly  

Vaccines, Viral

2009
A.M. Arvin, S.F. Chen
openaire   +1 more source

Vaccines against viral diarrhoea

Baillière's Clinical Gastroenterology, 1990
J, Flores, A Z, Kapikian
openaire   +2 more sources

SPLENECTOMY AND VIRAL VACCINES

The Pediatric Infectious Disease Journal, 1994
L, Doğanci, H, Gün
openaire   +2 more sources

Update on infection control practices in cancer hospitals

Ca-A Cancer Journal for Clinicians, 2018
Ella Ariza-Heredia, Roy F Chemaly
exaly  

Viral Vaccines

2016
Juliet Morrison, Stanley Plotkin
openaire   +1 more source